C Citigroup, Inc. Stock DD Sunday, March 30, 2014 8:26:35 PM

New Post Public Reply Private Reply Replies (0) Message Board

Mar 30, 2014 at 9:26 PM

C Citigroup, Inc. $C Company Overview

Stock Message Board http://investorshangout.com/search?q=C&ty...mp;yt1=Go!

Last Updated: Sunday, March 30, 2014 8:26:35 PM

Citigroup, Inc. C Current Price and Quotes
Last Price 47.25
Previous Close 47.45 Open 47.72
Daily Range 47.75 - 47.03 52wk Range 55.28 - 41.60
Volume 39,796,004 Dividend 0.04
Average Vol (3m) 29,703,443 Yield 0.084656
Citigroup, Inc. C
Company Information

399 Park Avenue
New York, NY 10043

Website: http://www.citigroup.com
Phone: 212-559-1000

Citigroup, Inc. C
Citigroup, Inc. C
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2013 10-K
CIK 0000831001
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=Travelers Group, Inc. until 10-98
Formerly=Travelers, Inc. until 4-95
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Citigroup, Inc. C
C Security Details Other Company Securities

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Security Notes

Issued=4-88 per reorganization of Commercial Credit Co. Basis: 1 for 1
Div=0.0432043 sh Travelers Property Casualty Corp. Class A Com and 0.0887656 sh Travelers Property Casualty Corp. Class B Com for each sh Com held. Ex-date=8-21-02. Rec-date=8-9-02. Pay-date=8-20-02.
Latest Additional Issue=4-30-08 178,076,770 shs at $25.27 per sh by Citigroup Global Markets Inc. sole underwriter. 5-1-08 underwriter exercised over-allotment option & purchased an additional 16,250,951 shs. Settlement date=5-5-08
Capital Change=shs increased by 4 for 3 split. Ex-date=08/28/2000. Rec date=08/07/2000. Pay date=08/25/2000.
Capital Change=shs decreased by 1 for 10 split. Pay date=05/09/2011.
Short Selling Data

Short Interest (%)
Significant Failures to Deliver No
Transfer Agent(s)

BNY Mellon

Citigroup, Inc. C Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 67,639,000 59,519,000 65,229,000 59,559,000
Cost of Revenue - - - -
Gross Profit 67,639,000 59,519,000 65,229,000 59,559,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 49,185,000 50,861,000 51,222,000 48,340,000
Non-Recurring Items 13,734,000 18,567,000 16,257,000 14,456,000
Other 7,684,000 10,442,000 11,387,000 25,077,000
Operating Income 19,284,000 9,545,000 14,979,000 10,773,000
Income From Continuing Operations

Add'l Income/Expense Items 748,000 3,251,000 1,997,000 2,411,000
Earnings Before Interest and Tax 35,674,000 28,437,000 38,931,000 38,280,000
Interest Expense 16,177,000 20,612,000 24,209,000 25,096,000
Earnings Before Tax 19,497,000 7,825,000 14,722,000 13,184,000
Income Tax 5,867,000 7,000 3,575,000 2,233,000
Minority Interest 227,000 219,000 148,000 281,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 13,630,000 7,818,000 11,147,000 10,951,000
Non Recurring Events

Discontinued Operations 270,000 (58,000) 68,000 (68,000)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 13,673,000 7,541,000 11,067,000 10,602,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 13,673,000 7,541,000 11,067,000 10,602,000

Citigroup, Inc. C Recent News

Mar 28, 2014 Celeste Applies to Alberta Security Commission for Management Cease Trade Order
Mar 28, 2014 Active Equities Watch List -- Research on Bank of America, Wells Fargo, Citigroup, and JPMorgan Chase
Mar 28, 2014 Fitch Affirms Citigroup's 'A' L-T IDR; Viability Rating Upgraded to 'a', Outlook Stable
Mar 28, 2014 Citigroup Shares Drop After Failing Fed Stress Test; Applied Genetic Technologies Announces IPO
Mar 27, 2014 Citigroup Announces $2 Billion Redemption of Trust Preferred Securities
Mar 27, 2014 Environmental Leader Announces 2014 Product & Project Award Winners
Mar 26, 2014 Citi Statement on 2014 CCAR Results
Mar 26, 2014 Fitch Takes Rating Action on Global Trading and Universal Banks Following Peer Review
Mar 26, 2014 C-Tracks ETNs Linked to the Miller/Howard MLP Fundamental Index (MLPC) To Pay Quarterly Coupon
Mar 25, 2014 Citi Names Heather Cox as Chief Client Experience, Digital and Marketing Officer for Global Consumer Banking

1
2
3
4
5
6
7
8
next >

C Citigroup, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=C&ty...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/C/quote
Stock Chart http://www.otcmarkets.com/stock/C/chart
Company Info http://www.otcmarkets.com/stock/C/company-info
Recent News http://www.otcmarkets.com/stock/C/news
Financials http://www.otcmarkets.com/stock/C/financials
Filings and Disclosure http://www.otcmarkets.com/stock/C/filings
Short Sales http://www.otcmarkets.com/stock/C/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/C/insider-transactions
Research Reports http://www.otcmarkets.com/stock/C/research
Summary http://finance.yahoo.com/q?s=C
Historical Prices http://finance.yahoo.com/q/hp?s=C+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=C
Basic Chart http://finance.yahoo.com/q/bc?s=C+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=C+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=C+Headlines
Press Releases http://finance.yahoo.com/q/p?s=C+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=C+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=C+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=C+Industry
Major Holders http://finance.yahoo.com/q/mh?s=C+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=C+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=C+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=C
Balance Sheet http://finance.yahoo.com/q/bs?s=C
Cash Flow http://finance.yahoo.com/q/cf?s=C+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/C
Market Watch http://www.marketwatch.com/investing/stock/C
Bloomberg http://www.bloomberg.com/quote/C:US
Morningstar http://quotes.morningstar.com/stock/s?t=C
Bussinessweek http://investing.businessweek.com/research/st...p?ticker=C
Barchart http://www.barchart.com/quotes/stocks/C
OTC Short Report http://otcshortreport.com/index.php?index=C
Investopedia http://www.investopedia.com/markets/stocks/C/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...